Atlantic Union Bankshares Reports First Quarter Results
RICHMOND, Va., April 28, 2020 (GLOBE NEWSWIRE) — Atlantic Union Bankshares Corporation (the “Company” or “Atlantic Union”) (Nasdaq: AUB) today […]
MacroGenics Announces Date of First Quarter 2020 Financial Results Conference Call
Rockville, MD, April 28, 2020 (GLOBE NEWSWIRE) —MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing […]
Kiniksa Reports First Quarter 2020 Financial Results and Highlights Recent Corporate and Pipeline Activity
– Financial guidance and clinical timelines for rilonacept, mavrilimumab, vixarelimab and KPL-404 remain intact amid COVID-19 pandemic –– Mavrilimumab treatment protocol in [...]
Primoris Services Corporation Announces Utility Award Valued at $105 Million
DALLAS, April 28, 2020 (GLOBE NEWSWIRE) — Primoris Services Corporation (NASDAQ Global Select: PRIM) (“Primoris” or “Company”) today announced the […]
Smile Direct Club Granted Patent for SmileShop Retail Concept and Treatment Process As Shops Plan to Reopen
Ensures no clear aligner competitor will be able to duplicate SDC unique model for 18 yearsCompany puts increased safety measures, social […]
Clearside Biomedical Revises NDA Resubmission Timeline and XIPERE™ Commercial Partnership with Bausch Health
– Management to Host Webcast and Conference Call Today at 8:30 A.M. ET –ALPHARETTA, Ga., April 28, 2020 (GLOBE NEWSWIRE) […]
Apellis Reports Analysis from Phase 1b Geographic Atrophy Study
No cases of inflammation observed after 12 months with Phase 3 formulation of pegcetacoplan in patients with advanced geographic atrophy […]
Balchem Releases 2019 Sustainability Report
NEW HAMPTON, N.Y., April 28, 2020 (GLOBE NEWSWIRE) — Balchem Corporation (NASDAQ: BCPC) today released its 2019 Sustainability Report, which […]
Antares Pharma to Report First Quarter 2020 Operating and Financial Results
EWING, N.J., April 28, 2020 (GLOBE NEWSWIRE) — Antares Pharma, Inc. (NASDAQ: ATRS) today announced it will release its first […]
RedHill Biopharma Strengthens Coverage for Talicia® with Preferred Brand Position on Prime Therapeutics NetResults™ National Formulary
Talicia® is the first and only FDA-approved rifabutin-based therapy for H. pylori infection, designed as a first-line option to address […]
